N01-AI-25461/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	1
2007	2
2008	1
2009	2
2010	1
2024	0

1

Cell-mediated immunity and the challenges for vaccine development.

Salerno-Gonçalves R, Sztein MB. Salerno-Gonçalves R, et al. Trends Microbiol. 2006 Dec;14(12):536-42. doi: 10.1016/j.tim.2006.10.004. Epub 2006 Oct 19. Trends Microbiol. 2006. PMID: 17055276 Review.

2

Comparison of three anthrax toxin neutralization assays.

Ngundi MM, Meade BD, Lin TL, Tang WJ, Burns DL. Ngundi MM, et al. Clin Vaccine Immunol. 2010 Jun;17(6):895-903. doi: 10.1128/CVI.00513-09. Epub 2010 Apr 7. Clin Vaccine Immunol. 2010. PMID: 20375243 Free PMC article.

3

Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.

Campbell JD, Clement KH, Wasserman SS, Donegan S, Chrisley L, Kotloff KL. Campbell JD, et al. Hum Vaccin. 2007 Sep-Oct;3(5):205-11. doi: 10.4161/hv.3.5.4459. Epub 2007 May 18. Hum Vaccin. 2007. PMID: 17881903 Clinical Trial.

4

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, Sigurdardottir B, Hoeper A, Graham IL, Edelman R, He F, Nino D, Capellan J, Ruben FL. Couch RB, et al. Vaccine. 2007 Nov 1;25(44):7656-63. doi: 10.1016/j.vaccine.2007.08.042. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17913310 Free PMC article. Clinical Trial.

5

Rapid licensure of a new, inactivated influenza vaccine in the United States.

Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL. Treanor JJ, et al. Hum Vaccin. 2005 Nov-Dec;1(6):239-44. doi: 10.4161/hv.1.6.2376. Epub 2005 Nov 5. Hum Vaccin. 2005. PMID: 17012883 Clinical Trial.

6

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.

Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM. Talbot HK, et al. Vaccine. 2008 Jul 29;26(32):4057-61. doi: 10.1016/j.vaccine.2008.05.024. Epub 2008 Jun 2. Vaccine. 2008. PMID: 18602726 Free PMC article. Clinical Trial.

7

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.

Keitel WA, Dekker CL, Mink C, Campbell JD, Edwards KM, Patel SM, Ho DY, Talbot HK, Guo K, Noah DL, Hill H. Keitel WA, et al. Vaccine. 2009 Nov 5;27(47):6642-8. doi: 10.1016/j.vaccine.2009.03.015. Epub 2009 Mar 25. Vaccine. 2009. PMID: 19773098 Free PMC article. Clinical Trial.

8

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.

Brady RC, Treanor JJ, Atmar RL, Keitel WA, Edelman R, Chen WH, Winokur P, Belshe R, Graham IL, Noah DL, Guo K, Hill H. Brady RC, et al. Vaccine. 2009 Aug 13;27(37):5091-5. doi: 10.1016/j.vaccine.2009.06.057. Epub 2009 Jul 3. Vaccine. 2009. PMID: 19577636 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year